BCLS I Investco, LP 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-14 5:25 pm Sale |
2020-12-10 | 13D | Dicerna Pharmaceuticals, Inc. DRNA |
BCLS I Investco, LP | 2,786,247 3.700% |
-904,556 (-24.51%) |
Filing |